Sreevatsa
Volume:
63 - Edition:
2 -
Apr/May/Jun -
1995
Treatment ot bacilliferous BL/LL cases with combined chemotherapy and immunotherapy
Kiran Katoch1;
Vishwa M. Katoch2;
Mohan Natrajan3;
Amarjit S. Bhatia4;
Sreevatsa5;
Umesh D. Gupta6;
Vishnu D. Sharma7;
Chanappa T. Shivannavar8;
Madhu A. Patil9;
Ved P. Bharadwaj10
Volume:
60 - Edition:
1 -
Jan/Feb/Mar -
1992
Can sandflies be the vector for leprosy?
Sreevatsa;
Bhavaneshwar K. Girdhar;
Ipe M. Ipe;
Kothapalli V. Desikan
Volume:
57 - Edition:
2 -
Apr/May/Jun -
1989
Results of a modified WHO regimen in highly bacilliferous BL/LL patients
Kiran Katoch1;
Gopal Ramu2;
Usha Ramanathan3;
Utpal Sengupta4;
Sreevatsa5;
Vishnu D. Sharma6;
Channappa T. Shivannavar7;
Vishwa M. Katoch8
Volume:
58 - Edition:
1 -
Jan/Feb/Mar -
1990
An attempt to demonstrate antinerve antibodies in leprosy sera using rabbit nerve as an antigen
Om Parkash;
Sreevatsa;
Utpal Sengupta
Volume:
56 - Edition:
1 -
Jan/Feb/Mar -
1988
Pyrazinamide as a part of combination therapy for BL and LL patients-a preliminary report
Kiran Katoch;
Sreevatsa;
Usha Ramanathan;
Gopal Ramu
Volume:
55 - Edition:
1 -
Jan/Feb/Mar -
1987
Comparative study of immunizing and delayed hypersensitivity eliciting antigens of Mycobacterium leprae, M. tuberculosis,M. vaccae, and M. bovis (BCG)
Sudhir Sinha;
Sreevatsa;
Sudhir K. Gupta;
Utpal Sengupta